Skip to main content

Exiqon Licenses microRNA IP From Max Planck Society, Rockefeller University

NEW YORK (GenomeWeb News) – Exigon has licensed more than 200 human and viral microRNA sequences for diagnostic applications from Rockefeller University and the Max Planck Society, the company said today. 

The two separate, co-exclusive license agreements were signed with Garching Innovation, the technology-transfer agency of the society and the university.

 
Financial details were not disclosed.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.